Drug Name: Loqtorzi Active Ingredient: toripalimab-tpzi Indication: To treat recurrent or metastatic nasopharyngeal carcinoma when used together with or following other therapies Approval Date: 10/27/2023 Company: Coherus BioSciences, Inc More:…
Drug Name: Agamree Active Ingredient: vamorolone Indication: To treat Duchenne muscular dystrophy Approval Date: 10/26/2023 Company: Santhera Pharmaceuticals (USA), Inc More: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215239s000lbl.pdf
Drug Name: Omvoh Active Ingredient: mirikizumab-mrkz Indication: To treat ulcerative colitis Approval Date: 10/26/2023 Company: Eli Lilly and Company More: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761279s000lbl.pdf
Microscopes enhanced with artificial intelligence (AI) could help clinical microbiologists diagnose potentially deadly blood infections and improve patients’ odds of survival, according to microbiologists at Beth Israel Deaconess Medical Center…
In partnership with GE Healthcare, Johns Hopkins Hospital use predictive AI techniques to improve the efficiency of patient operational flow. A task force, augmented with AI, quickly prioritized hospital activity…
Drug Name: Bimzelx Active Ingredient: bimekizumab Indication: To treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy Approval Date: 10/17/2023 Company: UCB, Inc…
CognitiveML by Iodine Software applies AI-enabled systems to improve mid-revenue cycle leakages, like resource optimization and increased response rates. Description The company’s system discovers client insights, ensures documentation accuracy and…
An AI-based software platform that solves operational challenges, including those related to emergency rooms and patient safety. Description The company’s automated platform helps prioritize patient illness and injury and tracks…
A digital pathology platform that uses AI to detect patterns in cancer cells. Description The company’s software helps pathology labs enhance data management and uses AI-powered image analysis to connect…
Drug Name: Zilbrysq Active Ingredient: zilucoplan Indication: To treat moderately to severely active ulcerative colitis in adults Approval Date: 10/17/2023 Company: UCB, Inc. More: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216834s000lbl.pdf